News Alerts

16 Aug 2018 | 12:46 AM UTC

Serbia: Nationwide measles outbreak continues /update 1

Serbia News Alert

Serbian health officials report 5715 measles cases nationwide between October 2017 and August 2018; ensure measles vaccinations are up to date

TIMEFRAME expected from 3/24/2018, 12:00 AM until 9/30/2018, 11:59 PM (Europe/Belgrade). COUNTRY/REGION Serbia

Read all related news alert(s):

Event

According to health officials, 5715 confirmed cases of measles were reported across Serbia from October 2017 through August 10, 2018. Of the total, 117 new cases were confirmed between June 21 and August 10. At least 15 fatalities have also been reported during the current outbreak due to complications from the disease. Approximately 95 percent of infected individuals were either partially or fully unvaccinated. Further spread of the outbreak is possible in the near-term.

Context

Measles is a highly contagious viral disease that typically affects mostly children. It is transmitted via droplets from the nose, mouth, or throat of infected persons. Symptoms of measles are usually a high fever, which begins approximately ten to 12 days after exposure to the virus and lasts four to seven days. A runny nose, a cough, red and watery eyes, and small white spots inside the cheeks can develop in the initial stage. After several days, a rash erupts, usually on the face and upper neck. Over the course of about three days, the rash spreads, eventually reaching the hands and feet. The rash lasts for five to six days and then fades. On average, the rash occurs 14 days after exposure to the virus (within a range of seven to 18 days). A vaccine is available.

Advice

Individuals in Serbia are advised to ensure their measles vaccination is up to date (including booster shots) and to contact their doctor with any questions or concerns. Anyone experiencing the above symptoms is urged to seek immediate medical attention.

 

Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news